Home LiteratureArticle Details
PMID: 3871945 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.

Cole JL, Housley GA, Dykman TR, MacDermott RP, Atkinson JP

Abstract

Proteins binding the third component of complement (C3) were isolated by affinity chromatography from surface-labeled solubilized membranes of human peripheral blood cells and cell lines. The isolated molecules were subjected to NaDodSO4/PAGE, and autoradiographs of these gels indicated that C3-binding proteins could be divided into three groups based on Mr: (i) gp200, an approximately 200,000 Mr molecule previously identified as the C3b/C4b receptor or CR1; (ii) gp140, an approximately 140,000 Mr molecule previously identified as the C3d receptor or CR2; and (iii) gp45-70, a heretofore unrecognized group of 45,000-70,000 Mr C3-binding molecules. The cell distribution, Mr, antigenic cross-reactivity, and specificity of gp45-70 were examined. Erythrocytes have no detectable gp45-70, but all leukocyte populations examined possess this group of molecules. On neutrophils and mononuclear phagocytes, CR1 is the predominant C3-binding glycoprotein, but gp45-70 is present on both cell populations and on macrophage and neutrophil cell lines. B plus null cells, chronic lymphocytic leukemia cells, and an Epstein-Barr virus-transformed B-cell line possess CR1, CR2, and gp45-70. On T cells and T-cell lines gp45-70 is the predominant or, in some cases, the only C3-binding protein isolated. gp45-70 is structurally characterized as a broad band or doublet with a mean Mr that is slightly different for each cell population. gp45-70 binds iC3, C3b, and C4b, but not C3d, indicating that the binding region is probably within the C3c portion of C3b. A polyclonal antibody to CR1 and monoclonal antibodies to CR1 and CR2 do not immunoprecipitate gp45-70. While gp45-70 has not been previously characterized on human cells, a C3b-binding glycoprotein of similar Mr is present on rabbit alveolar macrophages. We conclude that gp45-70 is an additional group of membrane proteins present on human leukocytes that possess ligand-binding activity for C3b.

MeSH Terms
B-Lymphocytes/analysis Carrier Proteins/analysis Cell Line Chromatography, Affinity Complement C3 Electrophoresis, Polyacrylamide Gel Humans Leukemia, Lymphoid/blood Leukocytes/analysis Membrane Proteins/analysis Molecular Weight Monocytes/analysis T-Lymphocytes/analysis
Chemicals
Carrier Proteins Complement C3 Membrane Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Cole J L
Housley G A
Dykman T R
MacDermott R P
Atkinson J P
References (29)
29 references, click to expand
  1. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  2. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
    J Exp Med. 1982 May 1;155(5):1427-38 PMID: 6978375
  3. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    J Exp Med. 1980 Jul 1;152(1):20-30 PMID: 6967510
  4. Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.
    J Immunol. 1981 Feb;126(2):693-8 PMID: 7005341
  5. Further characterization of the human autologous mixed leukocyte reaction (MLR).
    J Immunol. 1981 Feb;126(2):729-34 PMID: 6450250
  6. Characterization of a human B cell-specific antigen (B2) distinct from B1.
    J Immunol. 1981 May;126(5):1941-7 PMID: 6163824
  7. Isolation of a biologically active macrophage receptor for the third component of complement.
    Nature. 1981 Apr 30;290(5809):789-92 PMID: 7219564
  8. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
    J Immunol. 1981 Jul;127(1):104-8 PMID: 7240739
  9. Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid.
    J Immunol. 1981 Jul;127(1):109-14 PMID: 6909271
  10. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus.
    Lancet. 1981 Sep 5;2(8245):493-7 PMID: 6115248
  11. Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b.
    J Biol Chem. 1982 Feb 25;257(4):1595-7 PMID: 6460027
  12. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
    N Engl J Med. 1982 Oct 14;307(16):981-6 PMID: 7110302
  13. Polymorphism of human erythrocyte C3b/C4b receptor.
    Proc Natl Acad Sci U S A. 1983 Mar;80(6):1698-702 PMID: 6572933
  14. Complement receptors.
    Clin Immunol Rev. 1981-1982;1(4):471-545 PMID: 6762936
  15. Structural heterogeneity of the C3b/C4b receptor (Cr 1) on human peripheral blood cells.
    J Exp Med. 1983 Jun 1;157(6):2160-5 PMID: 6222138
  16. Human monocytes, B lymphocytes, and non-B lymphocytes each have structurally unique Fc gamma receptors.
    J Immunol. 1983 Jul;131(1):378-83 PMID: 6223075
  17. Characterization of human T lymphocytes that express the C3b receptor.
    J Immunol. 1983 Aug;131(2):684-9 PMID: 6223090
  18. Complement receptor expression by neoplastic and normal human cells.
    J Immunol. 1983 Aug;131(2):899-905 PMID: 6306108
  19. Genetic regulation of a structural polymorphism of human C3b receptor.
    J Clin Invest. 1983 Aug;72(2):685-93 PMID: 6223944
  20. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.
    Proc Natl Acad Sci U S A. 1983 Sep;80(18):5699-703 PMID: 6225125
  21. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    J Exp Med. 1983 Oct 1;158(4):1021-33 PMID: 6225820
  22. The human C3b receptor.
    Springer Semin Immunopathol. 1983;6(2-3):159-72 PMID: 6227098
  23. Characterization of the human receptor for T-cell growth factor.
    Proc Natl Acad Sci U S A. 1983 Nov;80(22):6957-61 PMID: 6417659
  24. Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus.
    J Exp Med. 1984 Mar 1;159(3):691-703 PMID: 6230413
  25. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Proc Natl Acad Sci U S A. 1984 Feb;81(3):881-5 PMID: 6230668
  26. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    J Exp Med. 1984 Nov 1;160(5):1558-78 PMID: 6238120
  27. Isolation and characterization of a C3b receptor-like molecule from membranes of a human B lymphoblastoid cell line (Raji).
    FEBS Lett. 1981 Dec 21;136(1):111-4 PMID: 6976275
  28. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release.
    J Immunol. 1982 May;128(5):2313-8 PMID: 6801135
  29. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71 PMID: 293688
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1985-02-00
Pages
859-63
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC397146
Subset
IM
Grants
NIAID NIH HHS · 1-P50-AI15322 · United States
NIADDK NIH HHS · 2-T32-AM-07279 · United States
NIADDK NIH HHS · AM07279-06 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]